Authors: DODDS E DUNCKLEY MG NAUJOKS K MICHAELIS U DICKSON G

Citation: E. Dodds et al., LIPOFECTION OF CULTURED MOUSE MUSCLE-CELLS - A DIRECT COMPARISON OF LIPOFECTAMINE AND DOSPER, Gene therapy, 5(4), 1998, pp. 542-551

Authors: PAULI C NAUJOKS K MUNDL H LANG S ZEIDLER R KASTENBAUER E WOLLENBERG B

Citation: C. Pauli et al., GENE-THERAPY OF HNSCC WITH LIPOSOMAL MEDIATED H-IL2 PLASMIDS - PHASE-1 STUDY, British Journal of Cancer, 77, 1998, pp. 1517-1517

Authors: PORTEOUS DJ DORIN JR MCLACHLAN G DAVIDSONSMITH H DAVIDSON H STEVENSON BJ CAROTHERS AD WALLACE WAH MORALEE S HOENES C KALLMEYER G MICHAELIS U NAUJOKS K HO LP SAMWAYS JM IMRIE M GREENING AP INNES JA

Citation: Dj. Porteous et al., EVIDENCE FOR SAFETY AND EFFICACY OF DOTAP CATIONIC LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS, Gene therapy, 4(3), 1997, pp. 210-218

Authors: LAURIE DJ BARTKE I SCHOEPFER R NAUJOKS K SEEBURG PH

Citation: Dj. Laurie et al., REGIONAL, DEVELOPMENTAL AND INTERSPECIES EXPRESSION OF THE 4 NMDAR2 SUBUNITS, EXAMINED USING MONOCLONAL-ANTIBODIES, Molecular brain research, 51(1-2), 1997, pp. 23-32

Authors: MCLACHLAN G HO LP DAVIDSONSMITH H SAMWAYS J DAVIDSON H STEVENSON BJ CAROTHERS AD ALTON EWFW MIDDLETON PG SMITH SN KALLMEYER G MICHAELIS U SEEBER S NAUJOKS K GREENING AP INNES JA DORIN JR PORTEOUS DJ

Citation: G. Mclachlan et al., LABORATORY AND CLINICAL-STUDIES IN SUPPORT OF CYSTIC-FIBROSIS GENE-THERAPY USING PCMV-CFTR-DOTAP, Gene therapy, 3(12), 1996, pp. 1113-1123

Authors: WOLLENBERG B NAUJOKS K KASTENBAUER E

Citation: B. Wollenberg et al., CONSIDERATIONS OF SOMATIC GENE-THERAPY IN HEAD AND NECK SQUAMOUS-CELLCANCER, Laryngo-, Rhino-, Otologie, 75(6), 1996, pp. 356-362